Cargando…
PIK3CA Mutation Analysis in Iranian Patients with Gastric Cancer
BACKGROUND: Aberrant activation of phosphatidylinositol-3 kinases (PI3K)/AKT/mTOR (mammalian target of rapamycin) pathway is a critical event during gastric cancer progression. Selective function of AKT inhibitor AZD5363 in PI3KCA mutant gastric cancer necessitates the assessment of PI3KCA mutations...
Autores principales: | Iranpour, Mostafa, Nourian, Mahyar, Saffari, Sana, Samizadeh, Esmaeil, Mirghafori, Mahdieh, Iravani, Shahrokh, Ghafouri-Fard, Soudeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pasteur Institute
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305827/ https://www.ncbi.nlm.nih.gov/pubmed/29704890 http://dx.doi.org/10.29252/.23.1.87 |
Ejemplares similares
-
Mutations of PIK3CA in gastric adenocarcinoma
por: Li, Vivian Sze Wing, et al.
Publicado: (2005) -
A comprehensive overview of identified mutations in SARS CoV-2 spike glycoprotein among Iranian patients
por: Eslami, Solat, et al.
Publicado: (2022) -
Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas
por: Murat, C.B., et al.
Publicado: (2012) -
Expression Study and Clinical Correlations of MYC and CCAT2 in Breast Cancer Patients
por: Sarrafzadeh, Shaghayegh, et al.
Publicado: (2017) -
ANRIL Genetic Variants in Iranian Breast Cancer Patients
por: Khorshidi, Hamid Reza, et al.
Publicado: (2017)